Qiagen N.V. (NYSE:QGEN) has announced two strategic partnerships designed to revolutionize minimal residual disease (MRD) ...

Measuring MRD ... NGS is excellent for initial biomarker discovery and tumor profiling but can be prohibitively expensive and time-consuming to use for continuous monitoring. Quantitative PCR ...

MRD testing uses highly sensitive methods such as flow cytometry, PCR, NGS, and other methods.These tests use bone marrow samples and/or peripheral blood cells (taken through a vein). Significant ...

After treatment, the identification of surviving cancer cells, or minimal residual disease (MRD ... PCR is helpful in situations where mutant copies are available, being able to look at a larger ...

to digital PCR, highlighting the assay's sensitivity and potential in clinical research for improving MRD detection. Learning Objectives Gain a deeper understanding of the diverse applications of next ...

The deals cover development and commercialization of next-generation sequencing and digital PCR assays for minimal residual disease detection.

In a study published in the journal Science Bulletin, researchers have therefore proposed to introduce blood minimal residual disease (MRD ... into PCR-based and next generation sequencing ...

that often go undetected by previous generations of PCR-based enrichment technologies. The ultra-sensitive detection of MRD in AML is a critical tool for advancing clinical research in AML. NGS-based ...

In the past few years, digital PCR (dPCR ... and next-generation sequencing (NGS), which is costly, complex in terms of workflow and analysis, and prone to variable false-positive rates. Identifying ...

HLA typing can be performed using numerous methods, including endpoint PCR, qPCR, Sanger sequencing, and next-generation sequencing (NGS). HLA typing has grown more accessible as NGS capabilities ...